nad has been researched along with Addison Disease and Cerebral Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreu, AL; Ferrer, I; Fourcade, S; Galino, J; García-Arumí, E; Guilera, C; Jove, M; López-Erauskin, J; Naudi, A; Pamplona, R; Portero-Otin, M; Pujol, A; Ruiz, M; Schlüter, A; Starkov, AA | 1 |
| Dacremont, G; Kemp, S; Ofman, R; Sanders, RJ; Wanders, RJ | 1 |
| Derwas, N; Poulos, A; Singh, H | 1 |
3 other study(ies) available for nad and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
Topics: Adenosine Triphosphate; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cells, Cultured; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Energy Metabolism; Glutathione; Humans; Male; Mice; Mice, Inbred C57BL; NAD; Oxidative Stress; Proteomics; Pyruvate Kinase | 2011 |
Characterization of the human omega-oxidation pathway for omega-hydroxy-very-long-chain fatty acids.
Topics: Adrenoleukodystrophy; Aldehyde Oxidoreductases; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dicarboxylic Acids; Fatty Acids; Humans; Lipid Metabolism; Metabolic Networks and Pathways; NAD; Oxidation-Reduction | 2008 |
Beta-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts.
Topics: Abnormalities, Multiple; Acyl Coenzyme A; Adenosine Triphosphate; Adrenoleukodystrophy; Cell Line; Fatty Acids; Fibroblasts; Humans; Kinetics; Magnesium; NAD; Oxidation-Reduction; Refsum Disease; Skin; X Chromosome | 1987 |